1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Cancer Tissue Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Cancer Tissue Diagnostics Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Europe Cancer Tissue Diagnostics Market Regional Analysis
6.1 Europe Cancer Tissue Diagnostics Market Overview
6.2 Europe Cancer Tissue Diagnostics Market Revenue 2016-2027 (US$ Million)
6.3 Europe Cancer Tissue Diagnostics Market Forecast Analysis
7. Europe Cancer Tissue Diagnostics Market Analysis – by Test Type
7.1 Immunohistochemical Tests and In Situ Hybridization Tests
- 7.1.1 Overview
- 7.1.2 Immunohistochemical Tests and In Situ Hybridization Tests: Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Cancer Tissue Diagnostics Market – Europe Analysis
8.1 Europe
- 8.1.1 Europe Cancer Tissue Diagnostics Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 8.1.1.1 Europe Cancer Tissue Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 8.1.1.1 UK:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.1.1 UK: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
- 8.1.1.2 Germany:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.2.1 Germany: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
- 8.1.1.3 France:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.3.1 France: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
- 8.1.1.4 Russia:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.4.1 Russia: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
- 8.1.1.5 Italy:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.5.1 Italy: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
- 8.1.1.6 Rest of Europe:
Europe Cancer Tissue Diagnostics Market – Revenue and Forecast to 2027 (US$ Million)
- 8.1.1.6.1 Rest of Europe: Europe Cancer Tissue Diagnostics Market Breakdown, by Test Type
9. Competitive Landscape
9.1 Heat Map Analysis
9.2 Company Positioning and Concentration
10. Europe Cancer Tissue Diagnostics Market Industry Landscape
10.1 Overview
10.2 Mergers and Acquisitions
10.3 Agreements, Collaborations, and Joint Ventures
10.4 New Product Launches
10.5 Expansions and Other Strategic Developments
11. Company Profiles
11.1 F. Hoffmann-La Roche Ltd
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Thermo Fisher Scientific Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Bio Rad Laboratories Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Abbott
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Enzo Life Sciences, Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Agilent Technologies, Inc.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Cancer Genetics Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Merck KGaA (Sigma-Aldrich Co. LLC)
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Danaher
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Abcam plc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
12. Appendix
12.1 About Business Market Insights
Get Free Sample For Europe Cancer Tissue Diagnostics Market
